FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Takes Actions to Curb Autism

FDA takes two actions against autism by ordering a label change against acetaminophen (Tylenol) use in pregnancy approving leucovorin calcium tablets ...

latest-news-card-1
Human Drugs

FDA Extends Review on Sanofi Multiple Sclerosis NDA

FDA extends by three months its review of Sanofis multiple sclerosis drug tolebrutinib to evaluate additional analyses submitted recently.

latest-news-card-1
Human Drugs

Roches Giredestrant Shows Promise in Breast Cancer

Roche reports positive Phase 3 data with its investigational breast cancer drug giredestrant.

latest-news-card-1
Human Drugs

FDA Issues Guidance on Malaria Drug Development

FDA posts a draft guidance entitled Malaria: Developing Drugs for Treatment that outlines key considerations for companies developing drugs targeting ...

latest-news-card-1
Human Drugs

Lexicon Submits New Data to FDA on Zynquista

Lexicon Pharmaceuticals says FDA is requiring additional time to review its new clinical data submitted earlier this month in an effort to advance its...

latest-news-card-1
Human Drugs

Priority Review for Rare Vision-Loss Disorder Drug

FDA accepts for priority review a Chiesi NDA for idebenone and its use in treating Leber hereditary optic neuropathy.

FDA General

Rep. Pallone Blasts RFK Jr. Over Vaccine Changes

Rep. Frank Pallone Jr. (D-NJ) sharply criticizes Health and Human Services Secretary Robert F. Kennedy Jr., accusing him of undermining vaccine access...

Medical Devices

FDA OKs Medtronics Altaviva Implant for Incontinence

FDA approves Medtronics Altaviva implantable tibial neuromodulation device for treating urge urinary incontinence.

Animal Drugs

10/9 Vaccines Panel to Recommend Flu Strain Selection

FDA schedules a 10/9 Vaccines and Related Biological Products Advisory Committee meeting to make recommendations on the strain selection for influenza...

latest-news-card-1
Human Drugs

Mercks Keytruda Qlex Approved by FDA

FDA approves Mercks pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for subcutaneous injection for adult and pediatric solid tumor indic...